The disease, which is characterized by non-malignant tumor (hamartoma) development in multiple organs and severe neurological manifestations, is caused by mutations in either of two tumor suppressor genes, TSC1 or TSC2. The existence of a significant genotype-phenotype correlation in individuals bearing mutations in TSC1 or TSC2 is a matter of debate. Here, TSC2 is linked to hamartoma.